Open Access

Established CVD and atherothrombosis: how did we get here and how can we get out

Seminar Presentation

About the speaker

Doctor Francisco Araujo

Hospital dos Lusiadas, Lisbon (Portugal)
1 presentation
0 follower

1 more presentation in this session

Icosapent Ethyl, a new player in reducing atherothrombotic risk?

Speaker: Professor V. Aboyans (Limoges, FR)


Access the full session

One step further in reducing established cardiovascular disease risk: targeting atherothrombosis after REDUCE-IT

Speakers: Doctor F. Araujo, Professor V. Aboyans

About the event


EuroThrombosis and EuroVessels 2022

20 October - 22 October 2022

ESC 365 is supported by

logo Novo Nordisk